Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001140361-18-023041
Filing Date
2018-05-11
Accepted
2018-05-11 16:02:49
Documents
70
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q form10q.htm 10-Q 902232
2 EXHIBIT 31.1 ex31_1.htm EX-31.1 12588
3 EXHIBIT 31.2 ex31_2.htm EX-31.2 12356
4 EXHIBIT 32.1 ex32_1.htm EX-32.1 7134
11 graphic1.jpg GRAPHIC 18726
  Complete submission text file 0001140361-18-023041.txt   5016448

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT rckt-20180331.xml EX-101.INS 767490
6 XBRL TAXONOMY EXTENSION SCHEMA rckt-20180331.xsd EX-101.SCH 46393
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rckt-20180331_cal.xml EX-101.CAL 45512
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rckt-20180331_def.xml EX-101.DEF 266087
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE rckt-20180331_lab.xml EX-101.LAB 714900
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rckt-20180331_pre.xml EX-101.PRE 393293
Mailing Address 430 EAST 29TH STREET SUITE 1040 NEW YORK NY 10016
Business Address 430 EAST 29TH STREET SUITE 1040 NEW YORK NY 10016 646-440-9100
ROCKET PHARMACEUTICALS, INC. (Filer) CIK: 0001281895 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36829 | Film No.: 18826823
SIC: 2834 Pharmaceutical Preparations